Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profile of OSSL_325096 treated myeloma cells

ABSTRACT: Gene expression profile of OSSL_325096 treated myeloma cells

PROVIDER: PRJNA485182 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7661925_1.fastq.gz	Fastqsanger.gz
	SRR7661925_2.fastq.gz	Fastqsanger.gz
	SRR7661926_1.fastq.gz	Fastqsanger.gz
	SRR7661926_2.fastq.gz	Fastqsanger.gz
	SRR7661927_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Gene expression profile of OSSL_325096 treated myeloma cells

Project description:OSSL_325096 is a compound that acts as p97/VCP inhibitor and induces apoptosis in myeloma cells. Therefore, we treated KMS12PE and KMS11 myeloma cell lines with OSSL_325096 or DMSO and compare gene expression levels to elucidate the mechanisms of apoptosis.

2019-08-30 | GSE118320 | GEO

Multiple myeloma cell lines expression profile of OTX015-treated cells compared to DMSO controls

Project description:Multiple myeloma cell lines expression profile of OTX015-treated cells compared to DMSO controls

| PRJNA436970 | ENA

Gene expression profile of myeloma cells treated with IGF-1

Project description:Objective of this study was to find changes in gene expression of mouse multiple myeloma cells upon treatment with IGF-1

2010-02-28 | GSE17140 | GEO

Gene expression profiles of myeloma cells treated with NAE inhibitor

Project description:The transcriptional profile of the human multiple myeloma (MM) cell line MM.1S treated with MLN4924 vs control MM.1S cells was characterized by oligonucleotide microarray analysis, using the human U133 plus 2.0 Affymetrix GeneChip, according to previously described protocols for total RNA extraction and purification; cDNA synthesis; in vitro transcription reaction for production of biotin-labeled cRNA; hybridization of cRNA with U133plus2.0 Affymetrix gene chips; and scanning of image output files. Scanned image output files were analyzed using DNA-Chip Analyzer (dChip) (www.dchip.org), including conversion to DCP files, normalization and modeling. The gene expression profile of MM.1S cells for each time point of MLN4924 treatment was compared to the profile of control MM.1S cells. The NEDD8 activating enzyme (NAE) is upstream of the 20S proteasome in the ubiquitin/proteasome pathway and catalyzes the first step in the neddylation pathway. NEDD8 modification of cullins is required for ubiquitination of cullin-ring ligases (CRLs), which regulate degradation of a distinct subset of proteins. The more targeted impact of NAE on protein degradation prompted us to study MLN4924, an investigational NAE inhibitor, in preclinical multiple myeloma (MM) models. In vitro treatment with MLN4924 led to dose-dependent decrease of viability in a panel of human MM cell lines. In this analysis, we evaluated the molecular changes triggered in MM.1S myeloma cells by their in vitro treatment with MLN4924. The transcriptional profiles of each experimental condition were characterized by oligonucleotide microarray analysis, using the human U133 plus 2.0 Affymetrix GeneChip. The human multiple myeloma (MM) cells MM.1S were cultured in vitro in the presence or absence of the NEDD8 activating enzyme (NAE) inhibitor MLN4924 for 8, 16 or 24hrs. The gene expression profiles of drug treated cells were compared with the profiles of control MM.1S cells.

2012-05-01 | E-GEOD-33577 | biostudies-arrayexpress

Gene expression profiles of myeloma cells treated with NAE inhibitor

2012-05-02 | GSE33577 | GEO

Gene expression profile of myeloma cells treated with IGF-1

Project description:Objective of this study was to find changes in gene expression of mouse multiple myeloma cells upon treatment with IGF-1 Murine multiple myeloma cells were incubated in serum free medium for 12 hours in the absence (3 replicates) or presence (3 replicates) of 100 ng/ml IGF-1

2010-03-09 | E-GEOD-17140 | biostudies-arrayexpress

Lenalidomide-induced changes in gene expression profile of multiple myeloma cells

Project description:Lenalidomide-induced changes in gene expression profile of multiple myeloma cells

| PRJNA782661 | ENA

Expression data from primary multiple myeloma plasma cells from patients treated by Total Therapy 2, 3 and Other protocols at baseline and relapse.

Project description:Global gene expression profile of primary multiple myeloma plasma cells from patients treated in Myeloma Institute for Research and Therapy was done using Affymetrix microarrays.

2015-08-13 | GSE31161 | GEO

Lenalidomide-induced changes in gene expression profile of multiple myeloma cells

Project description:We identified lenalidomide-induced changes in gene expression profile to identify IKZF1-regulated genes in multiple myeloma.

2022-11-18 | GSE189365 | GEO

Gene expression profile in multiple myeloma tumors from Vk*MYC mice

Project description:Myeloma tumors arose in Vk*MYC mice share gene expression profile with multiple myeloma tumors from human patients

2020-02-20 | GSE111921 | GEO